Anti-IgE was associated with a lower risk of congestive heart failure, peripheral artery disease, and stroke, whereas anti-IL5/IL5R was associated with a lower risk of congestive heart failure, arrythmia, and peripheral artery disease. This evidence concerns the gene IL5RA and congestive heart failure.